Case study · 2017-2018

PAREXEL Multi-Client Projects

Supporting global pharmaceutical leaders with regulatory intelligence, compliance strategies, and market access solutions across Africa.

PAREXEL
6+Global pharmaceutical clients
15+African markets covered
100%Regulatory compliance rate

01The challenge

PAREXEL needed a trusted regulatory partner to support multiple global pharmaceutical clients navigating Africa’s complex and diverse regulatory landscape.

  • Multiple jurisdictions with varying requirements
  • 6 major pharmaceutical clients (Novartis, Merck, P&G, Angelini, MSD, LEO Pharma)
  • Tight timelines for clinical trials and registrations
  • Complex documentation and compliance requirements

02Our solution

ECP delivered comprehensive regulatory consulting services tailored to each client’s specific needs:

Clinical trial label knowledge

Expert guidance on labeling requirements for clinical trials across African markets

Marketing authorization transfers

Facilitated smooth transfer of marketing authorizations between entities

Regulatory landscape assessments

Detailed assessments of regulatory requirements and timelines

Regulatory intelligence

Real-time intelligence on authorizations, variations, and changes

03Results & impact

Our partnership with PAREXEL delivered measurable, impactful outcomes:

  • 30% faster — approval timelines reduced
  • 100% compliance across all submissions
  • 15+ markets successfully accessed
  • Accelerated market access for critical medications
  • Zero regulatory setbacks or rejections
  • Cost savings through local expertise
  • Strategic insights for market expansion
“ECP's deep understanding of African regulatory requirements and their responsive, professional approach made them an invaluable partner for our multi-client projects. Their local expertise was instrumental in navigating complex regulatory landscapes.”
PAREXEL Project Lead
Begin

Ready to navigate Africa’s regulatory landscape?

Tell us about your product and target markets. An ECP specialist will respond with a clear next step.